Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Phenmetrazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 known ✓ | P23975 | 5/20 | 1.00 |
| ▸ | SLC6A3 known ✓ | Q01959 | 5/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 1/20 | 1.00 |
| ▸ | HTR2B | P41595 | 1/20 | 1.00 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.72 |
| ▸ | HTR1A | P08908 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TACR1 | P25103 | 5/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenmetrazine SCHEMBL265002 | 1.00 | SLC6A2 (1.00) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL15159761 | 1.00 | SLC6A2 (1.00) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL15154744 | 1.00 | SLC6A2 (1.00) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL8094204 | 1.00 | SLC6A2 (1.00) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL15159760 | 1.00 | SLC6A2 (1.00) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL22462307 | 0.98 | SLC6A2 (0.96) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL121536 | 0.98 | SLC6A2 (0.96) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL3341647 | 0.90 | SLC6A2 (0.81) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| SCHEMBL1666720 | 0.89 | SLC6A2 (0.80) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL28570473 | 0.86 | SLC6A2 (0.74) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5516 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026099249-A1 | MODIFIED AND UNMODIFIED PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE (PAM) FOR USE IN SUBJECTS HAVING INCREASED AMYLOID-BETA AND/OR PHOSPHO-TAU-PROTEIN LOAD AND/OR NEUROINFLAMMATION | PAM THERAGNOSTICS GMBH (DE) | 2026-05-15 | — | — | WO | claimed |
| CN-114008013-B | Treatment of CNS disorders with sleep disorders | 哥本哈根大学 | 2026-05-15 | — | — | CN | claimed |
| EP-4722714-A1 | SIMULTANEOUS ANALYSIS OF FOOD-BORNE DOPING SUBSTANCES USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (VFD: VACCINE FOR FOODBORNE DOPING) | Korea Institute of Science and Technology (KR) | 2026-04-08 | — | — | EP | claimed |
| US-20260027139-A1 | TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST | VIVUS, INC. | 2026-01-29 | — | — | US | claimed |
| US-12414936-B2 | Compositions comprising a serotonergic tryptamine compound | CAAMTECH, INC. (US) | 2025-09-16 | — | — | US | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| CN-119979776-A | Primer probe composition and kit for simultaneously detecting 17 pathogenic microorganisms in foods | 深圳市计量质量检测研究院 | 2025-05-13 | — | — | CN | claimed |
| US-20250122274-A1 | SELECTIVE AND POTENT INHIBITORY ANTIBODIES OF MYOSTATIN ACTIVATION | SCHOLAR ROCK, INC. | 2025-04-17 | — | — | US | claimed |
| US-20250032503-A1 | USE OF APREPITANT FOR TREATING ALZHEIMER'S DISEASE | HOTH THERAPEUTICS, INC. | 2025-01-30 | — | — | US | claimed |
| US-20250009720-A1 | METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA | APNIMED, INC. (DELAWARE) | 2025-01-09 | — | — | US | claimed |
| EP-0724450-A1 | COMPOSITION FOR WEIGHT REDUCTION CONTAINING EPHEDRINE AND A MINERAL SALT OR CHELATE | Keown, Wendy J. (US) | 1996-08-07 | — | — | EP | claimed |
| US-5543405-A | MIXTURE OF EPHEDRINE AND CHROMIUM PICOLINATE | KEOWN WENDY J (US) | 1996-08-06 | — | — | US | claimed |
| EP-0110955-B1 | BRAIN-SPECIFIC DRUG DELIVERY | UNIV FLORIDA (US) | 1995-08-23 | — | — | EP | claimed |
| WO-1995011034-A1 | COMPOSITION FOR WEIGHT REDUCTION CONTAINING EPHEDRINE AND A MINERAL SALT OR CHELATE | KEOWN WENDY J (US) | 1995-04-27 | — | — | WO | claimed |
| US-5096712-A | METHOD FOR ENHANCING PERFORMANCE SO AS TO IMPROVE VIGOR AND DECREASE FATIGUE, CONFUSION, TENSION, AND ANXIETY | INTERNEURON PHARMACEUTICALS, INC. (US) | 1992-03-17 | — | — | US | claimed |
| US-5019594-A | Method for decreasing appetite | INTERNEURON PHARMACEUTICALS, INC. (US) | 1991-05-28 | — | — | US | claimed |
| EP-0222425-A2 | Brain-specific drug delivery | UNIVERSITY OF FLORIDA (US) | 1987-05-20 | — | — | EP | claimed |
| EP-0218300-A2 | Brain-specific drug delivery | UNIVERSITY OF FLORIDA (US) | 1987-04-15 | — | — | EP | claimed |
| US-4557934-A | ALONG WITH A DIOL PYRROLIDONE OR AN AZACYCLOPENTAN-2-ONE | THE PROCTER & GAMBLE COMPANY (US) | 1985-12-10 | — | — | US | claimed |
| US-4255439-A | Means and method for aiding individuals to stop smoking | COOPER IRVING | 1981-03-10 | — | — | US | claimed |